Latest Content

The FDA approved Revtorpyk with fulvestrant, with or without Ibrance, for certain patients with advanced HR-positive, HER2-negative breast cancer.

The FDA upgraded its approval of Retevmo for adults and children 2 and older with RET fusion-positive solid tumors.

Chermaine Wulff of Valley Medical Center goes beyond clinical duties to champion her patients' final wishes, advocate for nursing staff and strengthen oncology nursing across the Pacific Northwest.

A cancer survivor shares why hearing "you'll be fine" can be difficult, and explains the ongoing anxiety, uncertainty and fear of cancer recurrence.

The first Balance Exercise Package for patients with cancer features tandem standing to improve balance, reduce fall risk and support everyday movement.

Kaitlyn Palsson, RN, of Utah Cancer Specialists, draws on her childhood Type 1 diabetes diagnosis and family history of cancer to bring deep empathy and purpose to every patient interaction.

Learn what angioimmunoblastic T-cell lymphoma is, how it's staged, how each stage is treated and what survivorship looks like.

Discover why walking with a partner can help cancer survivors stay safe, motivated and connected while improving physical and emotional well-being.

After reaching remission from stage 3B non-small cell lung cancer, one survivor shares the emotional journey of healing, hope and finding a new normal.

The FDA approved Keytruda plus Padcev before and after bladder surgery for adults with muscle-invasive bladder cancer, expanding treatment options.

The FDA approved Sarclisa Escena, a new subcutaneous treatment option for adults with multiple myeloma across newly diagnosed and relapsed settings.

ASCO 2026 findings and patient stories show how GLP-1 drugs improve metabolic health and potentially transform breast cancer survivorship.

Kristin Johnson, MSN, RN, OCN, of MD Anderson Cancer Center, combines clinical trials work with volunteer advocacy for ovarian cancer patients and survivors of human trafficking.